Serum Institute Gets Nod To Enroll 7-11 Years Old For Vaccine Trial

As per reports, India's drug regulator has allowed Covishield's maker Serum Institute of India (SII) to enroll children aged between seven to 11 years for its COVID-19 vaccine trial. The Central Drugs Standard Control Organisation's (CDSCO) subject expert panel made the recommendation after "detailed deliberation". SII is already conducting a trial of its COVID-19 vaccine in the 12-17 age group and has presented safety data for an initial 100 participants.